deltatrials
Recruiting OBSERVATIONAL NCT05169177

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy (ROCK-RT)

Sponsor: Austin Health

Conditions Liver Neoplasm
Updated 5 times since 2022 Last updated: Jul 29, 2024 Started: Oct 17, 2022 Primary completion: Oct 31, 2024 Completion: Oct 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Liver Neoplasm and is currently actively recruiting participants. Austin Health leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2022 – ~Jul 2023 · 18 months · monthly snapshotNot Yet Recruiting~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotRecruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotRecruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotRecruiting~Sep 2024 – present · 24 months · monthly snapshotRecruiting

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting

  2. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  3. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  4. Jul 2023 — Jul 2024 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2022 — Jul 2023 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Austin Health
  • Calvary Mater Newcastle, Australia
  • Peter MacCallum Cancer Centre, Australia
  • Princess Alexandra Hospital, Brisbane, Australia
  • University of Sydney
  • Western Sydney Local Health District
Data source: University of Sydney

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations